Biotage AB Financial Flexibility Index
Biotage AB financial flexibility index. Biotage AB (BIOT) has a Financial Flexibility Index of 0.09x as of March 2025. Free cash flow of Skr75.00 Million (operating CF Skr43.00 Million minus capex Skr32.00 Million) represents 0% of total liabilities (Skr862.00 Million). Explore Biotage AB capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Biotage AB (2002–2024)
Financial flexibility index of Biotage AB from 2002 to 2024. Historical Financial Flexibility Index trend for Biotage AB across 23 annual periods. Check cash flow reinvestment rate of Biotage AB to assess the company's total reinvestment commitment from operating cash flow.
Biotage AB Financial Flexibility Index by Year (2002–2024)
Biotage AB financial flexibility index by year from 2002 to 2024. Year-by-year free cash flow to debt coverage for Biotage AB. For the full cash flow conversion analysis, see BIOT operating cash flow.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.59x | Skr582.00 Million | Skr413.00 Million | Skr991.00 Million | ▲ +141.4% |
| 2023 | 0.24x | Skr310.00 Million | Skr284.00 Million | Skr1.27 Billion | ▼ -58.4% |
| 2022 | 0.59x | Skr411.00 Million | Skr341.00 Million | Skr702.00 Million | ▼ -11.2% |
| 2021 | 0.66x | Skr409.00 Million | Skr353.00 Million | Skr620.00 Million | ▼ -13.8% |
| 2020 | 0.77x | Skr339.99 Million | Skr279.05 Million | Skr444.40 Million | ▲ +36.9% |
| 2019 | 0.56x | Skr257.26 Million | Skr211.81 Million | Skr460.19 Million | ▼ -16.8% |
| 2018 | 0.67x | Skr202.16 Million | Skr155.00 Million | Skr301.02 Million | ▼ -51.7% |
| 2017 | 1.39x | Skr206.74 Million | Skr168.93 Million | Skr148.59 Million | ▼ -1.6% |
| 2016 | 1.41x | Skr186.61 Million | Skr139.07 Million | Skr131.96 Million | ▲ +13.6% |
| 2015 | 1.24x | Skr152.11 Million | Skr120.08 Million | Skr122.17 Million | ▲ +28.1% |
| 2014 | 0.97x | Skr113.08 Million | Skr80.91 Million | Skr116.36 Million | ▲ +14.4% |
| 2013 | 0.85x | Skr98.08 Million | Skr56.76 Million | Skr115.47 Million | ▼ -8.5% |
| 2012 | 0.93x | Skr114.43 Million | Skr74.47 Million | Skr123.24 Million | ▼ -17.1% |
| 2011 | 1.12x | Skr151.31 Million | Skr109.05 Million | Skr135.16 Million | ▲ +57.8% |
| 2010 | 0.71x | Skr89.04 Million | Skr57.59 Million | Skr125.48 Million | ▲ +30.0% |
| 2009 | 0.55x | Skr75.55 Million | Skr36.25 Million | Skr138.36 Million | ▼ -16.0% |
| 2008 | 0.65x | Skr113.20 Million | Skr88.74 Million | Skr174.22 Million | ▲ +45.2% |
| 2007 | 0.45x | Skr86.06 Million | Skr33.72 Million | Skr192.33 Million | ▲ +10.4% |
| 2006 | 0.41x | Skr83.00 Million | Skr39.91 Million | Skr204.79 Million | ▲ +3542.9% |
| 2005 | 0.01x | Skr2.63 Million | Skr-20.29 Million | Skr236.49 Million | ▲ +102.4% |
| 2004 | -0.46x | Skr-78.31 Million | Skr-97.89 Million | Skr172.03 Million | ▼ -18.7% |
| 2003 | -0.38x | Skr-83.30 Million | Skr-100.27 Million | Skr217.15 Million | ▲ +60.0% |
| 2002 | -0.96x | Skr-59.29 Million | Skr-127.02 Million | Skr61.88 Million | — |